INTR@PID
Showing 1 - 25 of 128
Lung Cancer, Cancer Trial in Rockland, Darmstadt, Madrid (Bintrafusp alfa)
Recruiting
- Lung Cancer
- Cancer
- Bintrafusp alfa
-
Rockland, Massachusetts
- +2 more
Dec 22, 2021
NSCLC Trial in Belgium, France, United States (Cisplatin, Carboplatin, Pemetrexed)
Completed
- Carcinoma, Non-Small-Cell Lung
- Cisplatin
- +7 more
-
Fountain Valley, California
- +18 more
Aug 10, 2022
NSCLC Trial in Worldwide (M7824, Placebo, Durvalumab)
Active, not recruiting
- Non-small Cell Lung Cancer
- M7824
- +8 more
-
Orange, California
- +103 more
Nov 24, 2022
Uterine Cervical Tumors Trial in Worldwide (Bintrafusp alfa)
Active, not recruiting
- Uterine Cervical Neoplasms
- Bintrafusp alfa
-
Fayetteville, Arkansas
- +72 more
Apr 7, 2022
Tool for Primary Immunodeficiency Disease (PID) in Pakistan
Not yet recruiting
- Primary Immunodeficiency Diseases
- Primary Immunodeficiency (PID) Rapid Diagnostic Test (RDT)
-
Karachi, PakistanAga Khan University Hospital
Feb 24, 2023
Test: A Performance Study With Primary Immunodeficiency Tunisia
Not yet recruiting
- Primary Immunodeficiency Diseases
- IgG deficiency rapid screening test
-
Tunis, TunisiaNational Bone Marrow Transplant center
Nov 10, 2022
Primary Immunodeficiency Trial in Ankara (Inspiratory muscle training, Upper extremity aerobic exercise training, Lower
Not yet recruiting
- Primary Immunodeficiency
- Inspiratory muscle training
- +4 more
-
Ankara, Çankaya, TurkeyGazi University, Faculty of Health Sciences, Department of Physi
Oct 14, 2023
Primary Immunodeficiency Disease Trial (Boya IVIG)
Not yet recruiting
- Primary Immunodeficiency Disease
- Boya IVIG
- (no location specified)
Nov 21, 2023
Systemic Sclerosis Trial in Tours (thoracic echography)
Completed
- Systemic Sclerosis
- thoracic echography
-
Tours, FranceCHRU Tours
Jun 17, 2022
Protracted Bacterial Bronchitis Trial in Stavanger (Amoxicillin-Clavulanate 400 Mg-57 Mg/5 mL Oral Powder for Reconstitution,
Recruiting
- Protracted Bacterial Bronchitis
- Amoxicillin-Clavulanate 400 Mg-57 Mg/5 mL Oral Powder for Reconstitution
- Placebo
-
Stavanger, NorwayStavanger University Hospital
Aug 28, 2023
Surgery Trial (Trans-vaginal ultrasound)
Not yet recruiting
- Surgery
- Trans-vaginal ultrasound
- (no location specified)
Nov 11, 2022
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
Cytomegalovirus Infections, Primary Immune Deficiency Disorder Trial in United States (viral specific cytotoxic t-lymphocytes)
Recruiting
- Cytomegalovirus Infections
- Primary Immune Deficiency Disorder
- viral specific cytotoxic t-lymphocytes
-
Los Angeles, California
- +7 more
Sep 27, 2022
Epstein-Barr Virus Infections, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)
Recruiting
- Epstein-Barr Virus Infections
- Primary Immune Deficiency Disorder
- cytotoxic t-lymphocytes
-
Los Angeles, California
- +7 more
Sep 27, 2022
Adenovirus, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)
Recruiting
- Adenovirus
- Primary Immune Deficiency Disorder
- cytotoxic t-lymphocytes
-
Los Angeles, California
- +8 more
Sep 27, 2022
Genital Chlamydia Trachomatis Infection Trial in Versailles (Testing for Ct infection immediately, Testing for Ct infection at
Active, not recruiting
- Genital Chlamydia Trachomatis Infection
- Testing for Ct infection immediately
- Testing for Ct infection at the end of the study
-
Versailles, Saint-Quentin-en-Yvelines, FranceUniversité de Versailles Saint Quentin
Mar 4, 2022
Suppurative Lung Disease in Children and Adults
Recruiting
- Primary Ciliary Dyskinesia
- +2 more
- Genetic Testing for PCD or PID
- Unaffected Family Member Genetic Testing
-
Palo Alto, California
- +7 more
Mar 30, 2022
Upper Airway Manifestations in Primary Ciliary Dyskinesia and
Recruiting
- Primary Ciliary Dyskinesia
- +2 more
-
Saint Louis, Missouri
- +3 more
Mar 30, 2022
Primary Immunodeficiency Disease Trial in United States (Kedrion IVIG 10%)
Completed
- Primary Immunodeficiency Disease
- Kedrion IVIG 10%
-
North Palm Beach, Florida
- +10 more
Jan 26, 2022
Exercise Capacity, Physical Activity Level and Quality of Life
Recruiting
- Primary Immunodeficiency Diseases
-
Ankara, Çankaya, TurkeyGazi University, Faculty of Health Sciences, Department of Physi
Aug 13, 2023
Primary Immune Deficiency Disorder Trial in United States (Bivigam, Other)
Active, not recruiting
- Primary Immune Deficiency Disorder
- Bivigam
- Other
-
Carpinteria, California
- +16 more
Jan 30, 2023
Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety
Recruiting
- Primary Immunodeficiency Diseases (PID)
-
Moscow, Russian FederationDmitry Rogachev National Research Center of Pediatric Hematology
Aug 8, 2023